Skip to main navigation

About

Our Story Executive Team Board of Directors

Technology and Platforms

Our Approach FasTCAR TruUCAR Manufacturing

Pipeline

Investors

Overview News & Events Financial Information Stock Information Corporate Governance IR Resources Contact Us

Media Coverage

Overview
News & Events
Financial Information
Stock Information
Corporate Governance
IR Resources
Contact Us

News & Events menu

Press Releases
Events & Presentations
In the News
Scientific Publications

Year

China CEO Interview: Gracell Aims To Enter US CAR-T Sector Through Partnerships, Faster Delivery

Nov 06, 2023

Source

SCRIP

William Cao, Gracell's CEO, Founder and Chair, named Trailblazer among 2023 PharmaVoice 100 Top Industry Leaders

Sep 19, 2023

Source

PharmaVoice

Gracell gives sneak peek into leukemia CAR-T cell program ahead of EHA

May 12, 2023

Source

Endpoints News

Rapid CAR T Manufacturing is About More Than Speed

Jan 20, 2023

Source

BioCentury

Gracell Biotechnologies’ quest to unlock the CAR-T bottleneck

Jan 09, 2023

Source

PharmaVoice

Gracell's CAR-T wows, Takeda puts down $4B on Nimbus' TYK2 inhibitor, Bio Farma strikes Merck deal

Dec 16, 2022

Source

Fierce Pharma Asia

ASH: In next BCMA myeloma race, Gracell dazzles with 100% response rate as Pfizer, BMS place their bets

Dec 12, 2022

Source

Fierce Biotech

Gracell Biotechnologies doses first patient in Phase 2 portion of registrational Phase 1/2 clinical trial evaluating treatment of B-cell acute lymphoblastic leukemia

Oct 20, 2022

Source

Drug Development & Delivery

Gracell continues progress in r/r B-Cell acute lymphoblastic leukemia

Oct 17, 2022

Source

CGT Live

Gracell Biotechnologies doses first patients in First-in-Human clinical trial evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin’s lymphoma

Feb 21, 2022

Source

Pharmtech Focus

Gracell doses first patients in First-in-Human clinical trial of dual-targeting CAR-T therapy

Feb 17, 2022

Source

Drug Development & Delivery

Gracell Biotechnologies begins treating B-NHL patients with CAR T-Cell therapy in trial

Feb 17, 2022

Source

Precision Oncology News

Shareholder Tools

Contact Us
Email Alerts
FAQs
RSS Feeds

Footer Links

Terms & Conditions
Privacy Policy
Contact Us
Careers

© 2023 Gracell All Rights Reserved.